Skip to main content

Table 5 Recurrence patterns of cT1 NSCLC with PSN and SN

From: Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer

 

Total Number

SN

PSN

Ratio c

P1

P2

Number

Incidence a

Percentage b

Number

Incidence a

Percentage b

Recurrence patterns

143

117

17.59%

100.00%

26

2.71%

100.00%

6.49

< 0.001

/

Locoregional only

18

14

2.11%

11.97%

4

0.42%

15.38%

5.02

0.003

0.743

Locoregional + distant

36

33

4.96%

28.21%

3

0.31%

11.54%

16.00

< 0.001

0.128

Distant only

83

65

9.77%

55.56%

18

1.88%

69.23%

5.20

< 0.001

0.290

Unclear

6

5

0.75%

4.27%

1

0.10%

3.85%

/

/

/

Sites of locoregional recurrence

        

Ipsilateral lung

31

26

3.91%

22.22%

5

0.52%

19.23%

7.52

< 0.001

0.943

N1 lymph node

11

11

1.65%

9.40%

0

0

0

/

< 0.001

0.215

N2 lymph node

35

33

4.96%

28.21%

2

0.21%

7.69%

23.62

< 0.001

0.041

Sites of distant recurrence

         

Bone

43

36

5.41%

30.77%

7

0.73%

26.92%

7.41

< 0.001

0.88

Brain

26

22

3.31%

18.80%

4

0.42%

15.38%

7.88

< 0.001

0.786

Contralateral lung

27

22

3.31%

18.80%

5

0.52%

19.23%

6.37

< 0.001

1

Pleura

24

20

3.01%

17.09%

4

0.42%

15.38%

7.17

< 0.001

1

Liver

12

11

1.65%

9.40%

1

0.10%

3.85%

16.50

< 0.001

0.695

Lymph node

9

7

1.05%

5.98%

2

0.21%

7.69%

5.00

0.037

0.667

Other sites

7

7

1.05%

5.98%

0

0

0

/

0.002

0.350

  1. PSN: part-solid nodules; SN: solid nodules; a: patients with recurrence/all patients with SN or PSN; b: Percentage of recurrence at each site /all patients with recurrence; c: Incidence in the SN group/incidence in the PSN group; P1: test for the incidence difference; P2: test for percentage difference